MedPath
HSA Approval

APO-ACEBUTOLOL TABLET 100 mg

SIN08621P

APO-ACEBUTOLOL TABLET 100 mg

APO-ACEBUTOLOL TABLET 100 mg

March 21, 1996

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C07AB04

acebutolol

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

ACEBUTOLOL HCl EQV ACEBUTOLOL

100 mg

Acebutolol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-ACEBUTOLOL TABLET 100 mg - HSA Approval | MedPath